On Wednesday, the FDA advised patients and health care providers that they would be adding a Boxed Warning to the medication glatiramer acetate, which is marketed as Copaxone or Glatopa. Patients undergoing treatment with glatiramer acetate, says the FDA, are at increased risk for anaphylaxis. […]
Jan 23, 2025
By TruLaw